Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Andes

Showing results (181-190 of 207) with videos related to

Pageof 21
Sort By:
Medical Mycology|June 12, 2012
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosisJohn W Baddley, David R Andes, Kieren A Marr, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
The <i>Candida albicans</i> reference strain SC5314 contains a rare, dominant allele of the transcription factor Rob1 that modulates biofilm formation and oral commensalismVirginia E Glazier, Juraj Kramara, Tomye Ollinger, et al.
Microbiology Spectrum|September 12, 2022
Validated Preclinical Mouse Model for Therapeutic Testing against Multidrug-Resistant Pseudomonas aeruginosa StrainsJonathan M Warawa, Xiaoxian Duan, Charles D Anderson, et al.
Medical Mycology|April 25, 2015
Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET)Todd P McCarty, John W Baddley, Thomas J Walsh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2010
Factors associated with mortality in transplant patients with invasive aspergillosisJohn W Baddley, David R Andes, Kieren A Marr, et al.
Nature Communications|August 1, 2024
Addendum: A small molecule produced by Lactobacillus species blocks Candida albicans filamentation by inhibiting a DYRK1-family kinaseJessie MacAlpine, Martin Daniel-Ivad, Zhongle Liu, et al.
Open Forum Infectious Diseases|March 14, 2024
Modeling Invasive Aspergillosis Risk for the Application of Prophylaxis StrategiesJo-Anne H Young, David R Andes, Monica I Ardura, et al.
Nature Communications|October 23, 2021
A small molecule produced by Lactobacillus species blocks Candida albicans filamentation by inhibiting a DYRK1-family kinaseJessie MacAlpine, Martin Daniel-Ivad, Zhongle Liu, et al.
Nature Communications|May 25, 2026
Large-scale investigation for antimicrobial activity reveals newly-identified defensive species across the healthy skin microbiomeUyen Thy Nguyen, Rauf Salamzade, Shelby Sandstrom, et al.
Science (New York, N.Y.)|November 20, 2020
A marine microbiome antifungal targets urgent-threat drug-resistant fungiFan Zhang, Miao Zhao, Doug R Braun, et al.
Pageof 21

Showing results (181-190 of 207) with videos related to

Sort By:
Pageof 21
Medical Mycology|June 12, 2012
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosisJohn W Baddley, David R Andes, Kieren A Marr, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
The <i>Candida albicans</i> reference strain SC5314 contains a rare, dominant allele of the transcription factor Rob1 that modulates biofilm formation and oral commensalismVirginia E Glazier, Juraj Kramara, Tomye Ollinger, et al.
Microbiology Spectrum|September 12, 2022
Validated Preclinical Mouse Model for Therapeutic Testing against Multidrug-Resistant Pseudomonas aeruginosa StrainsJonathan M Warawa, Xiaoxian Duan, Charles D Anderson, et al.
Medical Mycology|April 25, 2015
Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET)Todd P McCarty, John W Baddley, Thomas J Walsh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2010
Factors associated with mortality in transplant patients with invasive aspergillosisJohn W Baddley, David R Andes, Kieren A Marr, et al.
Nature Communications|August 1, 2024
Addendum: A small molecule produced by Lactobacillus species blocks Candida albicans filamentation by inhibiting a DYRK1-family kinaseJessie MacAlpine, Martin Daniel-Ivad, Zhongle Liu, et al.
Open Forum Infectious Diseases|March 14, 2024
Modeling Invasive Aspergillosis Risk for the Application of Prophylaxis StrategiesJo-Anne H Young, David R Andes, Monica I Ardura, et al.
Nature Communications|October 23, 2021
A small molecule produced by Lactobacillus species blocks Candida albicans filamentation by inhibiting a DYRK1-family kinaseJessie MacAlpine, Martin Daniel-Ivad, Zhongle Liu, et al.
Nature Communications|May 25, 2026
Large-scale investigation for antimicrobial activity reveals newly-identified defensive species across the healthy skin microbiomeUyen Thy Nguyen, Rauf Salamzade, Shelby Sandstrom, et al.
Science (New York, N.Y.)|November 20, 2020
A marine microbiome antifungal targets urgent-threat drug-resistant fungiFan Zhang, Miao Zhao, Doug R Braun, et al.
Pageof 21